1. Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada T2N 4N1;
2. Department of Medical Physiology, Institute of Medical Biology, University of Tromsø, N-9037 Tromsø, Norway; and
3. Department of Cardiovascular and Metabolic Diseases, Pfizer Global Research and Development, Groton, Connecticut 06340